T3 Pharmaceuticals

Pre-clinical

Basel, SwitzerlandFounded 2015t3pharma.com

Developing the next generation bacterial cancer therapy.

Market Cap

Private

Pipeline

—

Patents

—

Publications

—

Private Company

Total funding raised: $37M

Developing the next generation bacterial cancer therapy.

Drug DeliveryMicrobiome

Total raised:$37M

Series B$25MBioMedPartnersSep 15, 2020

Series A$12MNovartis Venture FundMay 15, 2018